AA |
Arachidonic acid |
ACE |
Angiotensin-converting enzyme |
ADP |
Adenosine diphosphate |
AGEs |
Advanced glycation end products |
Akt |
Protein kinase B |
AMI |
Acute myocardial infarction |
aPTT |
Activated partial thromboplastin time |
apoAI |
Apoplipoprotein A-I |
APS |
Antiphospholipid syndrome |
ASA |
Acetylsalicylic acid |
ASO |
Antisense oligonucleotides |
AT |
Antithrombin |
ATP |
Adenosine triphosphate |
cAMP |
Cyclic adenosine monophosphate |
CAT |
Catalase |
CCL |
Chemokine (C-C motif) ligand |
CD |
Cluster of differentiation |
CDT |
Catheter-directed thrombolysis |
CEP |
Centrosome-associated protein |
CHCL1 |
Chemokine induces the infiltration of neutrophils |
CLEC |
C-type lectin-like receptor |
COX |
Cyclooxygenase |
CT |
Computed tomography |
CX3CL1 |
Fractalkine |
CX3CR1 |
CX3C chemokine receptor 1 |
CXCL |
Chemokine CXC ligand-1 |
CYP |
Cytochrome P450 |
CypA |
Cyclophilin A |
DNA |
Deoxyribonucleic acid |
DVT |
Deep vein thrombosis |
eATP |
Extracellular ATP |
ECE |
Endothelin converting enzyme |
ECs |
Endothelial cells |
ED |
Endothelial dysfunction |
EDCF |
Endothelium-derived contracting factor |
EDGF |
Endothelium-derived growth factor |
EDHF |
Endothelium-derived hyperpolarizing factor |
EGF |
Epidermal growth factor |
EMP |
Microparticles of endothelial cells |
EMT |
Epithelial-mesenchymal transition |
eNOS |
Endothelial nitric oxide synthase |
ERK |
Extracellular signal-regulated kinase |
ETC |
Electron transport chain |
FGF |
Fibroblast growth factor |
GP |
Glycoprotein |
GSK |
Glycogen synthase kinase |
H2O |
Water |
H2O2
|
Hydrogen peroxide |
Hb |
Haemoglobin |
HClO |
Hypochlorous acid |
HIF |
Hypoxia inducible factor |
HNE |
4-hydroxy-2-nonenal |
HO•
|
Hydroxyl radical |
HO2•
|
Hydroperoxyl radical |
Hp |
Haptoglobin |
HRE |
Hormone response element |
HsCRP |
High-sensitivity C-reactive protein |
5HT2A |
Serotonin receptor 2A |
HUVEC |
Human umbilical vein endothelial cells |
Hx |
Hemopexin |
IAV |
Influenza A virus |
ICAM |
Intercellular adhesion molecule |
iCypA |
Extracellular cyclophilin A |
IDUs |
Intravenous drug users |
IFN |
Interferon |
IGF |
Insulin-like growth factor |
IL |
Interleukin |
iNOS |
Induced nitric oxide synthase |
INR |
International normalized ratio |
IVC |
Inferior vena cava |
IκBα |
Inhibitor of kappa B |
JAK-2 |
Janus kinase 2 |
JNK |
C-Jun N-terminal kinase |
LMWH |
Low molecular weight heparin |
LOX |
Lipoxygenase |
LPS |
Lipopolysaccharide |
MAPK |
Mitogen-activated protein kinases |
MCP |
Monocyte chemoattractant protein |
metHb |
Methaemoglobin |
MHC |
Major histocompatibility complex |
MIDAS |
Metal ion-dependent adhesion site |
MIP-2 |
Macrophage inflammatory protein 2 |
MKP-1 |
Mitogen-activated protein kinases phosphatase 1 |
MMP |
Matrix metalloproteinase |
MPO |
Myeloperoxidase |
MPV |
Mean platelets volume |
mPTP |
Mitochondrial permeability transition pore |
MRI |
Magnetic resonance imaging |
NAD+
|
Nicotinamide-adenine dinucleotide phosphate (oxidised form) |
NADPH |
Nicotinamide-adenine dinucleotide phosphate (reduced form) |
NAPc2 |
Nematode anticoagulant protein c2 |
NETs |
Neutrophil extracellular traps |
NF-κB |
Nuclear factor kappa B |
NLRP3 |
Inflammasome is component of the innate immune system |
NMMHC IIA |
Non-muscle myosin heavy chain IIa |
NO•
|
Nitric oxide |
NOX |
NADPH oxidase |
Nrf2 |
Nuclear factor erythroid 2-related factor 2 |
NSCLC |
Non-small-cell lung carcinoma |
O2
|
Oxygen |
1O2
|
Singlet oxygen |
O2•−
|
Superoxide anion radical |
ONOO−
|
Peroxynitrite |
ox-L |
Oxidised lipids |
ox-P |
Oxidised proteins |
oxyHb |
Oxyhaemoglobin |
PAF |
Platelet activating factor |
PAI-I |
Plasminogen activator inhibitor-1 |
PAR |
Protease-activated receptor |
PAT |
Percutaneous aspiration thrombectomy |
PCDT |
Catheter-directed pharmacomechanical thrombolysis |
PCI |
Percutaneous coronary intervention |
PD-L1 |
Programmed death-ligand 1 |
PDE3 |
Phosphodiesterase type 3 |
PDGF |
Platelet-derived growth factor |
PDI |
Protein disulfide-isomerase |
PE |
Pulmonary embolism |
PF |
Platelet factor |
PGE |
Prostaglandin E |
PGG |
Prostaglandin G |
PGH |
Prostaglandin H |
PGI |
Prostacycline |
PI3Kβ |
Phosphatidylinositol 3 kinase β |
PKA |
Protein kinase A |
PKC |
Protein kinase C |
PLa |
Activated platelets |
PLA |
Phospholipase A |
PLC |
Phospholipase C |
PLCγ2 |
Phospholipase Cγ2 |
PMN |
Polymorphonuclear leukocyte |
PMQ |
Pentamethyl quercetin |
PNS |
Saponins Panax notoginseng
|
PPAR-γ |
Peroxisome proliferator-activated receptor γ |
PSGL-1 |
P-selectin glycoprotein ligand-1 |
PT |
Prothrombin time |
PTS |
Polygala fallax Hesml root saponin extract |
RBCs |
Red blood cells |
RNA |
Ribonucleic acid |
ROS |
Reactive oxygen species |
SBSI |
Simultaneous decrease in prostacyclin synthase |
SLO |
Streptolysin O |
SLS |
Streptolysin S |
SOD |
Superoxide dismutase |
STAT3 |
Signal transducer and activator of transcription 3 |
STEC |
Shigatoxigenic Escherichia coli
|
TF |
Tissue factor |
TGF-β |
Transforming growth factor beta |
TLR |
Toll-like receptor |
TNF-α |
Tumour necrosis factor alfa |
t-PA |
Tissue plasminogen activator |
TRAP |
Thrombin receptor activator peptide |
TTP |
Thrombocytopenic purpura |
TXA2 |
Tromboxan A2 |
UFH |
Unfractionated heparin |
UV |
Ultraviolet |
VCAM |
Vascular cell adhesion molecule |
VEGF |
Vascular endothelial growth factor |
VKORC1 |
Vitamin K epoxide reductase complex |
VSMCs |
Vascular smooth muscle cells |
VTE |
Venous thromboembolism |
vWF |
Von Willebrand factor |